BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23349767)

  • 1. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.
    Zhang X; Sun Q; Shan M; Niu M; Liu T; Xia B; Liang X; Wei W; Sun S; Zhang Y; Liu XS; Song Q; Yang Y; Ma Y; Liu Y; Yang L; Ren Y; Zhang G; Pang D
    PLoS One; 2013; 8(1):e53931. PubMed ID: 23349767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
    Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
    Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.
    Wang D; Li C; Zhang X
    DNA Cell Biol; 2014 Sep; 33(9):581-90. PubMed ID: 24842653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
    Acun T; Senses KM
    Breast Cancer; 2020 May; 27(3):483-489. PubMed ID: 31902119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.
    Zhou W; Jiang Z; Liu N; Xu F; Wen P; Liu Y; Zhong W; Song X; Chang X; Zhang X; Wei G; Yu J
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):91-102. PubMed ID: 18670789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].
    Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
    Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
    Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.
    Huang KT; Takano EA; Mikeska T; Byrne DJ; Dobrovic A; Fox SB
    Breast Cancer Res Treat; 2011 Nov; 130(1):319-29. PubMed ID: 21755341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Tumour Biol; 2011 Feb; 32(1):23-32. PubMed ID: 20697987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
    Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
    Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis.
    Chen L; Zhu Z; Sun X; Dong XY; Wei J; Gu F; Sun YL; Zhou J; Dong JT; Fu L
    Breast Cancer Res Treat; 2009 Aug; 116(3):471-8. PubMed ID: 18686028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
    Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
    Wang D; Yang PN; Chen J; Zhou XY; Liu QJ; Li HJ; Li CL
    Mol Cell Biochem; 2014 Nov; 396(1-2):67-77. PubMed ID: 25148870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.